We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$5.84B
AUM Growth
-$102M
Cap. Flow
-$81.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
30.11%
Holding
477
New
17
Increased
91
Reduced
260
Closed
22

Top Buys

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$42.5M
2
TSM icon
TSMC
TSM
+$29.8M
3
WWD icon
Woodward
WWD
+$26.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$21.3M
5
ABT icon
Abbott
ABT
+$18.1M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$34.3M
2
UNH icon
UnitedHealth
UNH
+$22.9M
3
AMAT icon
Applied Materials
AMAT
+$20.5M
4
NVDA icon
NVIDIA
NVDA
+$18.1M
5
JPM icon
JPMorgan Chase
JPM
+$14M

Sector Composition

Rank Sector Weight
1 Technology 22.39%
2 Healthcare 14.95%
3 Financials 14.63%
4 Industrials 10.63%
5 Consumer Discretionary 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
151
CME Group
CME
$94.8B
$4.58M 0.08%
17,268
EQT icon
152
EQT Corp
EQT
$33.8B
$4.58M 0.08%
85,702
+18,698
+28% +$955K
WPM icon
153
Wheaton Precious Metals
WPM
$60.6B
$4.55M 0.08%
58,581
+719
+1% +$48K
CCI icon
154
Crown Castle
CCI
$31.3B
$4.47M 0.08%
42,870
-2,319
-5% -$217K
FOUR icon
155
Shift4
FOUR
$3.41B
$4.44M 0.08%
54,379
+7,588
+16% +$782K
AMGN icon
156
Amgen
AMGN
$226B
$4.4M 0.08%
14,119
-1,375
-9% -$406K
DD icon
157
DuPont de Nemours
DD
$19.1B
$4.32M 0.07%
46,092
-3,038
-6% -$296K
GS icon
158
Goldman Sachs
GS
$301B
$4.29M 0.07%
7,852
+367
+5% +$221K
CMCSA icon
159
Comcast
CMCSA
$89.4B
$4.21M 0.07%
114,168
-35,990
-24% -$1.3M
SNPS icon
160
Synopsys
SNPS
$78.8B
$4.2M 0.07%
9,805
-4,686
-32% -$2.28M
NVR icon
161
NVR
NVR
$16.8B
$4.05M 0.07%
559
-334
-37% -$2.54M
MTD icon
162
Mettler-Toledo International
MTD
$28.6B
$3.98M 0.07%
3,371
-96
-3% -$123K
IAU icon
163
iShares Gold Trust
IAU
$65.1B
$3.79M 0.06%
64,359
GILD icon
164
Gilead Sciences
GILD
$165B
$3.75M 0.06%
33,501
-1,134
-3% -$117K
EMR icon
165
Emerson Electric
EMR
$88.5B
$3.67M 0.06%
33,516
-385
-1% -$46.4K
STT icon
166
State Street
STT
$51.3B
$3.67M 0.06%
40,953
-651
-2% -$62.2K
PM icon
167
Philip Morris
PM
$290B
$3.56M 0.06%
22,397
-1,827
-8% -$259K
NVO
168
Novo Nordisk
NVO
$211B
$3.45M 0.06%
49,649
-8,115
-14% -$670K
ALC icon
169
Alcon
ALC
$35.9B
$3.29M 0.06%
+34,648
New +$3.11M
IJH icon
170
iShares Core S&P Mid-Cap ETF
IJH
$127B
$3.28M 0.06%
56,218
-2,708
-5% -$168K
PANW icon
171
Palo Alto Networks
PANW
$314B
$3.24M 0.06%
19,006
-113
-0.6% -$20.9K
USB icon
172
US Bancorp
USB
$100B
$3.22M 0.06%
76,254
-293
-0.4% -$13.5K
ASML icon
173
ASML
ASML
$666B
$3.14M 0.05%
4,732
+743
+19% +$541K
KMB icon
174
Kimberly-Clark
KMB
$35.9B
$3.01M 0.05%
21,151
-22
-0.1% -$2.96K
NVS icon
175
Novartis
NVS
$298B
$3.01M 0.05%
26,958
-1,800
-6% -$192K

Similar funds

Bradley Foster & Sargent's Q1 2025 Portfolio in Review

As of Q1 2025, Bradley Foster & Sargent held 477 positions worth $5.84B, down 1.7% from $5.95B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bradley Foster & Sargent's Q1 2025 filing shows 17 new, 91 increased, 260 reduced and 22 closed positions. Its largest new stake was Ball Corp: 809,638 shares worth $42.2M. The largest sale was S&P Global, an estimated $34.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q1 2025 buy was Ball Corp: 809,638 shares worth $42.2M.
  • Bradley Foster & Sargent added most to TSMC in Q1 2025, an estimated $29.8M increase.
  • Bradley Foster & Sargent's biggest Q1 2025 reduction was S&P Global, cutting an estimated $34.3M.
  • Bradley Foster & Sargent fully exited Equifax in Q1 2025, selling an estimated $2.8M.
  • Bradley Foster & Sargent's ten largest holdings make up 30% of its $5.84B portfolio in Q1 2025.
  • Bradley Foster & Sargent opened 17 new positions and closed 22 in Q1 2025.
  • Bradley Foster & Sargent's portfolio value fell 1.7% quarter-over-quarter to $5.84B.

Based on Bradley Foster & Sargent's 13F filing for Q1 2025, filed 13 May 2025.